These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 17308149)

  • 1. Prevention and management of ovarian hyperstimulation syndrome.
    Vlahos NF; Gregoriou O
    Ann N Y Acad Sci; 2006 Dec; 1092():247-64. PubMed ID: 17308149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights in mechanisms for development of ovarian hyperstimulation syndrome.
    Kasum M
    Coll Antropol; 2010 Sep; 34(3):1139-43. PubMed ID: 20977119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor response to exogenous chorionic gonadotropic hormone in the luteal phase of women with a history of severe ovarian hyperstimulation syndrome.
    Griesinger G; Dafopoulos K; Schultze-Mosgau A; Jelkmann W; von Otte S; Diesing D; Diedrich K
    Arch Gynecol Obstet; 2006 Apr; 274(1):29-33. PubMed ID: 16408189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention and treatment of ovarian hyperstimulation syndrome.
    Dourron NE; Williams DB
    Semin Reprod Endocrinol; 1996 Nov; 14(4):355-65. PubMed ID: 8988530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ovarian hyperstimulation syndrome--a risk of treatment for infertility].
    Bangsbøll S
    Nord Med; 1997 Sep; 112(7):236-9. PubMed ID: 9380489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of the evidence base of strategies to prevent ovarian hyperstimulation syndrome.
    Mathur R; Kailasam C; Jenkins J
    Hum Fertil (Camb); 2007 Jun; 10(2):75-85. PubMed ID: 17564886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiology and pathology of ovarian hyperstimulation syndrome.
    Gómez R; Soares SR; Busso C; Garcia-Velasco JA; Simón C; Pellicer A
    Semin Reprod Med; 2010 Nov; 28(6):448-57. PubMed ID: 21082502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome.
    Rizk B; Aboulghar M; Smitz J; Ron-El R
    Hum Reprod Update; 1997; 3(3):255-66. PubMed ID: 9322101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on management of ovarian hyperstimulation syndrome.
    Chen CD; Wu MY; Chao KH; Lien YR; Chen SU; Yang YS
    Taiwan J Obstet Gynecol; 2011 Mar; 50(1):2-10. PubMed ID: 21482366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is vascular endothelial growth factor (VEGF) the main mediator in ovarian hyperstimulation syndrome (OHSS)?
    Ajonuma LC
    Med Hypotheses; 2008; 70(6):1174-8. PubMed ID: 18164141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Function of vascular endothelial growth factor in ovarian hyperstimulation syndrome].
    Liang W; Chen S; Xing F
    Zhonghua Fu Chan Ke Za Zhi; 2001 Nov; 36(11):651-3. PubMed ID: 11930687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ovarian hyperstimulation syndrome].
    Le Gouez A; Naudin B; Grynberg M; Mercier FJ
    Ann Fr Anesth Reanim; 2011 Apr; 30(4):353-62. PubMed ID: 21398079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The "ART" of thromboembolism: a review of assisted reproductive technology and thromboembolic complications.
    Chan WS; Dixon ME
    Thromb Res; 2008; 121(6):713-26. PubMed ID: 17659766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thrombotic risk in assisted reproductive technology].
    Alatri A; Tribout B; Gencer B; Calanca L; Mazzolai L
    Rev Med Suisse; 2011 Feb; 7(281):357-60. PubMed ID: 21416715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Odds of ovarian hyperstimulation syndrome (OHSS) - time for reassessment.
    Mocanu E; Redmond ML; Hennelly B; Collins C; Harrison R
    Hum Fertil (Camb); 2007 Sep; 10(3):175-81. PubMed ID: 17786650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Future developments to minimize ART risks.
    Marzal A; Holzer H; Tulandi T
    Semin Reprod Med; 2012 Apr; 30(2):152-60. PubMed ID: 22549715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome.
    Soares SR; Gómez R; Simón C; García-Velasco JA; Pellicer A
    Hum Reprod Update; 2008; 14(4):321-33. PubMed ID: 18385260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian hyperstimulation syndrome and complications of ART.
    Vloeberghs V; Peeraer K; Pexsters A; D'Hooghe T
    Best Pract Res Clin Obstet Gynaecol; 2009 Oct; 23(5):691-709. PubMed ID: 19632900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous calcium infusion as a novel preventive therapy of ovarian hyperstimulation syndrome for patients with polycystic ovarian syndrome.
    Gurgan T; Demirol A; Guven S; Benkhalifa M; Girgin B; Li TC
    Fertil Steril; 2011 Jul; 96(1):53-7. PubMed ID: 21621772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined jugular and subclavian vein thrombosis following assisted reproductive technology--new observation.
    Salomon O; Schiby G; Heiman Z; Avivi K; Sigal C; Levran D; Dor J; Itzchak Y
    Fertil Steril; 2009 Aug; 92(2):620-5. PubMed ID: 18710711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.